Net profit of Ajanta Pharma rose 10.88% to Rs 232.88 crore in the quarter ended December 2024 as against Rs 210.03 crore during the previous quarter ended December 2023. Sales rose 3.71% to Rs 1146.13 crore in the quarter ended December 2024 as against Rs 1105.15 crore during the previous quarter ended December 2023.
Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
Sales | 1146.13 | 1105.15 | 4 |
OPM % | 27.99 | 28.42 | - |
PBDT | 343.36 | 325.17 | 6 |
PBT | 307.39 | 290.91 | 6 |
NP | 232.88 | 210.03 | 11 |